1. Definition and Epidemiology

An ectopic pregnancy is a pregnancy in which the embryo implants outside the uterine cavity. It occurs in roughly 2% of all pregnancies and is a significant cause of maternal morbidity and mortality, especially in the first trimester. Early identification and prompt management are critical to prevent complications such as internal hemorrhage and shock.

Common Sites of Ectopic Pregnancy

• Fallopian Tube (~95% of all ectopic pregnancies)
  • Ampulla: ~75–80%
  • Isthmus: ~12%
  • Fimbrial end: ~5%
  • Interstitial (cornual): ~2–3%
• Cervical Pregnancy (~0.15%)
• Ovarian Pregnancy (~0.15–3%)
• Cesarean Scar Pregnancy (~1 in 1,800 pregnancies)
• Abdominal Pregnancy (~1.3%)
• Heterotopic Pregnancy (~1 in 30,000 spontaneously, but up to ~1% in assisted reproductive techniques)

---

2. Risk Factors

Although anyone who becomes pregnant can experience an ectopic pregnancy, certain factors increase the likelihood:

---

3. Clinical Presentation

3.1 Symptoms

1. Lower Abdominal/Pelvic Pain: The most common symptom, reported in ~95% of cases.
2. Abnormal Vaginal Bleeding: Light to moderate spotting or bleeding.
3. Missed Menstrual Period: Often the first clue to possible pregnancy.
4. Possible Nausea and Vomiting: Some patients experience mild GI upset.

3.2 Signs

1. Adnexal Tenderness: Pain on palpation of the adnexa (the region of the ovaries and fallopian tubes).
2. Cervical Motion Tenderness: Noted on pelvic exam when moving the cervix side to side.
3. Palpable Adnexal Mass: Present in ~20% of cases.
4. Slightly Enlarged Uterus: May occur in ~25% of cases due to hormonal influence.
5. Signs of Rupture/Hemoperitoneum: Hypotension, tachycardia, rebound tenderness, referred shoulder tip pain (due to diaphragmatic irritation by blood).

---

4. Diagnosis

Ectopic pregnancy cannot be confirmed by history and physical exam alone. Laboratory tests and imaging are essential.

4.1 Serum β-hCG Testing

• Detectable ~8–10 days post-ovulation.
• Quantitative Levels:
  • Discriminatory Zone (for TVS): ~1,500 mIU/mL. If no intrauterine sac is seen above this level, suspect ectopic.
  • Normal intrauterine pregnancy typically shows β-hCG doubling (~66% increase) every 48 hours in early gestation.
  • Slower rises or plateauing levels are suspicious for ectopic or failing pregnancy.

4.2 Ultrasound Examination

Transvaginal ultrasound (TVS) is the gold standard for identifying an intrauterine or extrauterine pregnancy:

1. No Intrauterine Gestational Sac at β-hCG > 1,500 mIU/mL → high suspicion of ectopic.
2. Adnexal Findings:
   • Tubal Ring Sign – A thick echogenic ring around a gestational sac in the tube.
   • Ring of Fire Sign (Doppler) – Increased blood flow surrounding an ectopic mass.
   • Bagel (Donut) Sign – A ring-like mass consistent with an ectopic.
   • Blob Sign – A small, less-defined mass near the ovary or tube without a clear ring structure.
   • Pseudogestational Sac – A fluid collection in the uterine cavity that lacks the double-decidual sign; can mimic an intrauterine sac but is not a true gestational sac.
3. Hemoperitoneum: Free fluid in the pouch of Douglas or peritoneal cavity, suggesting rupture and internal bleeding.

4.3 Additional Diagnostic Steps

• Dilatation & Curettage (D&C): If the diagnosis remains unclear, endometrial sampling can determine if villi are present (which would indicate an intrauterine pregnancy). Absence of villi suggests ectopic or pregnancy of unknown location.
• Laparoscopy: Considered the gold standard for direct visualization but usually reserved for cases where immediate surgery is indicated or where noninvasive modalities cannot clarify the diagnosis.

---

5. Management

Management strategies depend on clinical stability, β-hCG levels, ultrasound findings, and patient preferences. Three main approaches:

5.1 Expectant Management

• Suitable for asymptomatic or minimally symptomatic patients.
• Generally considered if β-hCG is low (<1,000 mIU/mL) and is declining by >50% in 7 days.
• Requires close follow-up with repeated β-hCG measurements until levels are undetectable.

5.2 Medical Management

Methotrexate (MTX) is the mainstay for treating unruptured ectopic pregnancies under specific conditions:

• Criteria for MTX:
  1. Hemodynamically stable, no evidence of intra-abdominal bleeding.
  2. Gestational sac <4 cm without fetal cardiac activity (some protocols allow up to 3.5–4 cm with no heartbeat).
  3. β-hCG <5,000 mIU/mL (lower levels have higher success rates).
  4. Patient can attend follow-up appointments reliably.
  5. Normal liver and renal function, normal blood counts.
• Contraindications:
  • Intraperitoneal bleeding or ruptured ectopic.
  • Significant hepatic, renal, or hematologic disorders.
  • Inability to comply with follow-up.
• Single-Dose Regimen:
  • MTX 50 mg/m^2 IM (intramuscular) once.
  • Check β-hCG on days 4 and 7. A decrease of >15% between days 4 and 7 indicates likely success; continue weekly checks until undetectable. If <15% decrease, a second MTX dose may be required.
• Patient Instructions:
  • Avoid folic acid supplements and NSAIDs during treatment (interference with MTX action).
  • Avoid alcohol.
  • Monitor for increased abdominal pain (can be “separation pain” but always evaluate for rupture).

5.3 Surgical Management

Indicated if:

• The patient is hemodynamically unstable (suspected rupture, significant intra-abdominal bleeding).
• Contraindications to MTX or medical therapy failure.
• Large ectopic mass or fetal cardiac activity in the tube.

Two main surgical options:

1. Salpingostomy (conservative): Incision in the fallopian tube to remove the ectopic pregnancy, leaving the tube to heal. Requires follow-up β-hCG to ensure complete removal.
2. Salpingectomy (radical): Removal of the affected fallopian tube, often chosen if the tube is severely damaged or future fertility is not a priority.

---

6. OSCE-Focused Approach

In an OSCE station on ectopic pregnancy, you may be asked to:

1. Take a Focused History
   • Chief Complaint: Pelvic pain, vaginal bleeding, dizziness.
   • Obstetric History: LMP (last menstrual period), previous ectopic or miscarriages.
   • Gynecologic History: Contraceptive use, PID, prior pelvic surgery, fertility treatments.
   • Risk Factors: Smoking, DES exposure, multiple sexual partners, etc.
2. Perform a Focused Examination
   • Vital Signs: Look for tachycardia or hypotension.
   • Abdominal Exam: Tenderness, guarding, or rebound (suggestive of internal bleeding).
   • Pelvic Exam: Cervical motion tenderness, adnexal tenderness, possible adnexal mass.
3. Interpret an Ultrasound
   • Identify no intrauterine sac with β-hCG above the discriminatory zone.
   • Look for adnexal mass with a “ring of fire” sign on Doppler or free fluid in the pouch of Douglas.
4. Outline a Management Plan
   • Stable: Consider medical (MTX) or expectant management if criteria are met.
   • Unstable: Immediate surgical intervention (salpingostomy or salpingectomy).
5. Counsel the Patient
   • Explain the diagnosis (ectopic pregnancy risks).
   • Discuss management options (risks, benefits, follow-up).
   • Emphasize the possibility of future ectopic (~10–14% recurrence risk).
   • Stress the importance of early prenatal care in subsequent pregnancies.

---

7. Differential Diagnoses to Consider

• Threatened or Incomplete Miscarriage: Vaginal bleeding and abdominal pain, but with an intrauterine sac or passage of tissue.
• Ovarian Cyst Rupture/Torsion: Acute onset, severe pain, adnexal mass on ultrasound.
• Acute Appendicitis: RLQ pain with possible fever, rebound tenderness.
• Renal/Ureteric Stone: Flank pain radiating to the groin, hematuria on urinalysis.
• Pelvic Inflammatory Disease (PID): Cervical motion tenderness with abnormal discharge, often fever.

---

8. Emergency Management at a Glance

1. Assess Stability: BP, HR, RR, temp.
2. Resuscitation: IV fluids, crossmatch blood if needed.
3. Immediate Ultrasound: Check for rupture (free fluid in the pelvis).
4. Labs: CBC, β-hCG, blood type/Rh.
5. Definitive Treatment: If shock or suspected rupture, proceed to urgent surgery (laparoscopy or laparotomy). Stable cases may allow for methotrexate or expectant management, depending on criteria.

---

9. Patient Counseling and Follow-Up

• Future Risk: 10–14% chance of recurrent ectopic.
• Early Check in Next Pregnancy: Patients should have an early scan/β-hCG check to rule out recurrent ectopic.
• Lifestyle Modifications: Quit smoking, reduce risk factors.
• Contraception Advice: Tailor to patient’s desire for future fertility.
• Emotional Support: An ectopic pregnancy can be distressing; offer psychological or counseling support.

---

Key Takeaways for OSCE Success

1. Structured History: Emphasize LMP, pain character, bleeding, prior ectopic, PID, and risk factors.
2. Focused Exam: Vital signs for stability, abdominal and pelvic findings for tenderness/masses.
3. Diagnostic Mastery: Understand β-hCG trends and ultrasound signs (Ring of Fire, Tubal Ring, etc.).
4. Clear Management Path: Know the criteria for expectant, medical (MTX), and surgical management.
5. Empathetic Counseling: Explain options, follow-up requirements, and potential impact on future fertility.

Final Word

Ectopic pregnancy is a critical obstetric emergency. In an OSCE setting, show you can recognize the condition, diagnose it accurately using β-hCG and ultrasound, and manage it promptly based on the patient’s clinical status. By combining systematic clinical skills, solid theoretical knowledge, and clear communication, you’ll be well-prepared to excel in any ectopic pregnancy OSCE station.